Thomas J Herzog. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents, Hormonal/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useClinical Trials, Phase II as TopicDrug SynergismEndometrial Neoplasms/drug therapyEndometrial Neoplasms/metabolismFemaleHumansMedroxyprogesterone Acetate/administration & dosageMegestrol Acetate/administration & dosageNeoplasm Recurrence, Local/drug therapyNeoplasm Recurrence, Local/metabolismReceptors, Progesterone/metabolismTamoxifen/administration & dosage
Substances: See more » Antineoplastic Agents, HormonalReceptors, ProgesteroneTamoxifenMedroxyprogesterone AcetateMegestrol Acetate
Year: 2004 PMID: 14751129 DOI: 10.1016/j.ygyno.2003.11.014
Source DB: PubMed Journal: Gynecol Oncol ISSN: 0090-8258 Impact factor: 5.482